Project Description

Strategy Inc. assisted our company with the development of an Investor Presentation and a Valuation Top Line clarifying the value proposition of our novel technologies. Strategy Inc. also performed due diligence to support closing our first round 6 Million Euros investment from Ysios Capital Partners, La Caixa and ICO Axis – an exciting time for our company. We sincerely appreciated the efforts and deliverables of Strategy Inc. and are pleased to be able to move to the next stage of our development.” Victor Garcia Llorente. Operations Director and Vincent Ribas Ripoll R&D Director

SabirMedical, is an applied research company located in the Bio-Incubator Science Park in Barcelona Spain focused in the development of novel technologies for diagnosis, home and patient care. SabirMedical’s initial technology is a game changing non-invasive cardiac monitoring technology.